Acknowledging Infection Risk in Bispecific Antibody Trials in the Treatment of Multiple Myeloma
- Author(s)
- Cliff, ERS; Reynolds, G; Popat, R; Teh, BW; Kesselheim, AS; Mohyuddin, GR;
- Details
- Publication Year 2023-04-01,Volume 41,Issue #10,Page 1949-1951
- Journal Title
- Journal of Clinical Oncology
- Publication Type
- Commentary
- Publisher
- American Society of Clinical Oncology
- Keywords
- Humans; *Multiple Myeloma/therapy; *Antibodies, Bispecific/adverse effects; Cell Line, Tumor
- Department(s)
- Infectious Diseases
- PubMed ID
- 36716411
- Publisher's Version
- https://doi.org/10.1200/JCO.22.02197
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-01-22 06:17:24
Last Modified: 2025-01-22 06:17:35